Integrated proteomics and metabolomics analyses reveal new insights into the antitumor effects of valproic acid plus simvastatin combination in a prostate cancer xenograft model associated with downmodulation of YAP/TAZ signaling
Abstract Background Despite advancements in therapeutic approaches, including taxane-based chemotherapy and androgen receptor-targeting agents, metastatic castration-resistant prostate cancer (mCRPC) remains an incurable tumor, highlighting the need for novel strategies that can target the complexit...
Zapisane w:
| Główni autorzy: | , , , , , , , , |
|---|---|
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
BMC
2024-11-01
|
| Seria: | Cancer Cell International |
| Hasła przedmiotowe: | |
| Dostęp online: | https://doi.org/10.1186/s12935-024-03573-1 |
| Etykiety: |
Nie ma etykietki, Dołącz pierwszą etykiete!
|